As the arsenal of biologic therapies for patients with psoriasis continues to grow, managed care professionals are increasingly challenged with ensuring appropriate patient selection within the context of value-based care.
In this webinar, experts in psoriasis and managed care round up and interpret the latest evidence needed to differentiate new and emerging therapies.
The experts will also explain data that demonstrate important differences in treatment efficacy in psoriasis compared with other inflammatory diseases.
Top 3 reasons to attend:
- Get cutting-edge evidence with major implications for psoriasis care;
- Ask the experts your most pressing questions; and
- Test your knowledge through live audience participation in case-based decisions.